Two British birth cohorts find no added health burden from a coastal childhood

Two British birth cohorts find no added health burden from a coastal childhood

Researchers analyzing two British birth cohorts found no association between coastal residence in adolescence and midlife multimorbidity, while an unadjusted association in the 1958 cohort weakened after accounting for n…

expert reaction to comparison of NICE criteria with the BOADICEA multifactorial risk model to guide breast cancer risk assessment and referral amongst women under age 50

A study published in the British Journal of Cancer compares the NICE criteria with the BOADICEA risk model for breast cancer risk ... read more

Breast cancer checks missing most women under 50 who are at risk, says study

Breast cancer checks missing most women under 50 who are at risk, says study

Up to 95% of younger women who are at higher risk of developing breast cancer are being missed by current NHS checks, researchers warn.

Breast cancer checks missing most women under 50 who are at risk, says study - BBC

Breast cancer checks missing most women under 50 who are at risk, says study BBC Only 5% of high risk breast cancer cases spotted in referral rules The Independent NICE criteria miss up to 95% of under-50s later developi…

Autism expert warns spectrum may have become ‘too broad’

Autism expert warns spectrum may have become ‘too broad’

Kestra Medical Technologies CEO sells $692k in shares

Kestra Medical Technologies CEO sells $692k in shares

Breast screening misses 95 per cent of young women who go on to develop cancer, study suggests

Breast screening misses 95 per cent of young women who go on to develop cancer, study suggests

Health service breast screening misses 95 per cent of young women who go on to develop cancer , researchers have found.

Breast cancer screening 'missing 95% of those at higher risk', Cambridge study suggests

Breast cancer screening 'missing 95% of those at higher risk', Cambridge study suggests

The criteria given to GPs to refer women at risk of breast cancer for further tests or specialist care miss up to 95% of patients under 50 who go on to develop the disease within a decade, analysis suggests.

NICE referral criteria miss up to 95% of women under 50 who go on to develop breast cancer within 10 years

NICE referral criteria miss up to 95% of women under 50 who go on to develop breast cancer within 10 years

NICE referral criteria miss up to 95% of women under 50 who go on to develop breast cancer within 10 years Craig Brierley Tue, 08/04/2026 - 02:00 Using BOADICEA – a comprehensive risk assessment tool developed at the Uni…